These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

120 related items for PubMed ID: 38436929

  • 1. Clinical Outcomes and Implications of Radioactive Iodine Therapy on Cancer-specific Survival in WHO Classification of FTC.
    Li G, Ye Z, Wei T, Zhu J, Li Z, Lei J.
    J Clin Endocrinol Metab; 2024 Aug 13; 109(9):2294-2305. PubMed ID: 38436929
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Clinical Implication of World Health Organization Classification in Patients with Follicular Thyroid Carcinoma in South Korea: A Multicenter Cohort Study.
    Jin M, Kim ES, Kim BH, Kim HK, Yi HS, Jeon MJ, Kim TY, Kang HC, Kim WB, Shong YK, Kim M, Kim WG.
    Endocrinol Metab (Seoul); 2020 Sep 13; 35(3):618-627. PubMed ID: 32981304
    [Abstract] [Full Text] [Related]

  • 4. Follicular thyroid carcinoma: the role of histology and staging systems in predicting survival.
    Lo CY, Chan WF, Lam KY, Wan KY.
    Ann Surg; 2005 Nov 13; 242(5):708-15. PubMed ID: 16244545
    [Abstract] [Full Text] [Related]

  • 5. Survival benefit of postoperative radioiodine therapy among patients with intermediate-risk differentiated thyroid carcinoma.
    Wang J, Mao Y, Li L, Liang J, Huang H, Lin W, Chen G, Wen J.
    Endocrine; 2024 Nov 13; 86(2):664-671. PubMed ID: 38809346
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Radioactive iodine therapy strategies for distinct types of differentiated thyroid cancer: a propensity score-matched analysis.
    Guo H, Zhang N, Hu Y, Zhang F, Huang T, Shen N.
    Front Endocrinol (Lausanne); 2023 Nov 13; 14():1158581. PubMed ID: 37664843
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Follicular and Hurthle Cell Carcinoma: Comparison of Clinicopathological Features and Clinical Outcomes.
    Matsuura D, Yuan A, Wang L, Ranganath R, Adilbay D, Harries V, Patel S, Tuttle M, Xu B, Ghossein R, Ganly I.
    Thyroid; 2022 Mar 13; 32(3):245-254. PubMed ID: 35078345
    [Abstract] [Full Text] [Related]

  • 13. Follicular thyroid carcinoma in an iodine-replete endemic goiter region: a prospectively collected, retrospectively analyzed clinical trial.
    Asari R, Koperek O, Scheuba C, Riss P, Kaserer K, Hoffmann M, Niederle B.
    Ann Surg; 2009 Jun 13; 249(6):1023-31. PubMed ID: 19474675
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Comparison of prognosis between oncocytic thyroid carcinoma and follicular thyroid carcinoma: a population-based propensity score matching analysis.
    Peng H, Ding HL, Li XL, Wang WY, Wang XL, Gu J.
    Eur Arch Otorhinolaryngol; 2024 Sep 11. PubMed ID: 39259318
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.